On Sep. 22, 2017, GE Healthcare announced a new Protein A chromatography resin, MabSelect PrismA, for improving monoclonal antibody (mAb) purification capacity by up to 40%. The resin is alkaline-stable, meaning it can be cleaned with a higher concentration of sodium hydroxide, offering better cOriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.